Vertraagde tijd
Japan Exchange
02:29:28 21-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
509
JPY
|
+0,99%
|
|
+1,39%
|
+3,45%
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
11.530
|
6.020
|
5.001
|
5.141
|
3.046
|
3.791
|
Bedrijfswaarde
1 |
10.138
|
5.148
|
4.254
|
4.627
|
2.771
|
3.411
|
K/w-verhouding
|
-211
x
|
-36,1
x
|
-7,07
x
|
-16,2
x
|
-11,8
x
|
-13,1
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
15,2
x
|
7,71
x
|
8,68
x
|
8,54
x
|
4,71
x
|
4,77
x
|
Bedrijfswaarde/omzet
|
13,4
x
|
6,59
x
|
7,39
x
|
7,69
x
|
4,28
x
|
4,3
x
|
Bedrijfswaarde/EBITDA
|
35,1
x
|
-
|
-
|
-
|
-
|
-
|
Bedrijfswaarde/FCF
|
97,7
x
|
-28,6
x
|
-10,7
x
|
-32,7
x
|
-14,4
x
|
28,5
x
|
FCF Yield
|
1,02%
|
-3,49%
|
-9,34%
|
-3,06%
|
-6,94%
|
3,51%
|
Price to Book
|
6,03
x
|
2,91
x
|
2,57
x
|
3,16
x
|
2,23
x
|
3,52
x
|
Aantal aandelen (in duizenden)
|
7.897
|
8.419
|
9.313
|
9.313
|
9.313
|
9.313
|
Referentieprijs
2 |
1.460
|
715,0
|
537,0
|
552,0
|
327,0
|
407,0
|
Datum van publicatie
|
29/06/18
|
28/06/19
|
29/06/20
|
30/06/21
|
30/06/22
|
30/06/23
|
Fiscaal tijdperk: March |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
758
|
781
|
576
|
602
|
647
|
794
|
EBITDA
1 |
289
|
-
|
-
|
-
|
-
|
-
|
Bedrijfsresultaat (EBIT)
1 |
-49
|
-173
|
-596
|
-241
|
-122
|
52
|
Operationele Marge
|
-6,46%
|
-22,15%
|
-103,47%
|
-40,03%
|
-18,86%
|
6,55%
|
Resultaat voor belastingen (EBT)
1 |
-52
|
-164
|
-659
|
-310
|
-250
|
-280
|
Nettowinst (verlies)
1 |
-52
|
-167
|
-668
|
-318
|
-258
|
-289
|
Nettomarge
|
-6,86%
|
-21,38%
|
-115,97%
|
-52,82%
|
-39,88%
|
-36,4%
|
WPA
2 |
-6,927
|
-19,79
|
-75,99
|
-34,14
|
-27,70
|
-31,03
|
Free Cash Flow
1 |
103,8
|
-179,8
|
-397,5
|
-141,6
|
-192,2
|
119,9
|
FCF-marge
|
13,69%
|
-23,02%
|
-69,01%
|
-23,53%
|
-29,71%
|
15,1%
|
Kasstroomconversie (ebitda)
|
35,9%
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
29/06/18
|
28/06/19
|
29/06/20
|
30/06/21
|
30/06/22
|
30/06/23
|
Fiscaal tijdperk: Maart |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Nettokaspositie
1 |
1.392
|
872
|
747
|
514
|
275
|
380
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
104
|
-180
|
-398
|
-142
|
-192
|
120
|
ROE (netto-inkomsten/eigen vermogen)
|
-3,1%
|
-8,02%
|
-32,6%
|
-17,8%
|
-17,2%
|
-23,6%
|
ROA (netto-inkomsten/totale activa)
|
-0,91%
|
-3,44%
|
-13,9%
|
-7,16%
|
-4,3%
|
2,07%
|
Totale activa
1 |
5.706
|
4.852
|
4.806
|
4.444
|
5.994
|
-13.957
|
Nettoactief per aandeel
2 |
242,0
|
246,0
|
209,0
|
175,0
|
147,0
|
116,0
|
Cashflow per aandeel
2 |
301,0
|
177,0
|
111,0
|
64,90
|
54,50
|
65,90
|
Capex
|
-
|
-
|
-
|
13
|
-
|
-
|
Capex/omzet
|
-
|
-
|
-
|
2,16%
|
-
|
-
|
Datum van publicatie
|
29/06/18
|
28/06/19
|
29/06/20
|
30/06/21
|
30/06/22
|
30/06/23
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +3,45% | 30,14 mln. | | +34,35% | 693 mld. | | +29,39% | 584 mld. | | -3,49% | 372 mld. | | +20,15% | 332 mld. | | +6,19% | 294 mld. | | +14,11% | 239 mld. | | -3,03% | 211 mld. | | +10,02% | 210 mld. | | +9,21% | 168 mld. |
Farmaceutische producten - Andere
|